Abscopal effect after hypofractionated radiotherapy in metastatic renal cell carcinoma pretreated with pazopanib.

Cerbone, Luigi; Rebuzzi, Sara Elena; Lattanzi, Elisabetta; Gnetti, Letizia; Iaia, Maria Laura; D'Abbiero, Nunziata; Buti, Sebastiano

Cerbone, Luigi; Rebuzzi, Sara Elena; Lattanzi, Elisabetta; Gnetti, Letizia; Iaia, Maria Laura; D'Abbiero, Nunziata; Buti, Sebastiano.

Afiliación

Cerbone L; Academic Unit of Medical Oncology, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Rebuzzi SE; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Lattanzi E; Radiotherapy Unit, University Hospital of Parma, Parma, Italy.
Gnetti L; Pathology Unit, University Hospital of Parma, Parma, Italy.
Iaia ML; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
D'Abbiero N; Radiotherapy Unit, University Hospital of Parma, Parma, Italy.
Buti S; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.

Immunotherapy ; 2020 Jul 28.

Article en En | MEDLINE | ID: mdl-32723023

Palabras clave

MET; PD-L1; abscopal effect; hypofractionated; mTOR pathway; pazopanib; radiotherapy; renal cell carcinoma; tumor microenvironment; tumor-infiltrating lymphocytes

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Immunotherapy Asunto de la revista: ALERGIA E IMUNOLOGIA / TERAPEUTICA Año: 2020 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google